Ledger.Open graph →
SEC Form D · Amendment · filed August 5, 2024

Diceros Therapeutics, Inc

Offering
$18.1M
Sold
$12.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEWTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Jonathan R. Fleming · Newton, MADirectorStephen R. Seiler · Newton, MAExec · DirectorNelson E. Lamis · Aventura, FLExec · DirectorParis Malde · Camana Bay, Grand Cayman, Cayman IslandsDirectorIds R. Van Der Weij · Newton, MADirectorWyatt R. Gotbetter · Newton, MADirectorEyal I. Wagner · Gibraltar, J1DirectorThomas Warman · Wilmington, DEExec · DirectorIds R. Van Der Weij · Newton, MADirectorWyatt R. Gotbetter · Newton, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗